{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:04:04Z","timestamp":1784167444392,"version":"3.55.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/03007995.2023.2191479","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T08:49:41Z","timestamp":1678870181000},"page":"1585-1591","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey"],"prefix":"10.1080","volume":"39","author":[{"given":"Purnima","family":"Pathak","sequence":"first","affiliation":[{"name":"Novartis Ireland Ltd, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyu","family":"Yue","sequence":"additional","affiliation":[{"name":"Cerner Enviza, Malvern, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaloo","family":"Gupta","sequence":"additional","affiliation":[{"name":"Cerner Enviza, Malvern, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanzhi","family":"Fang","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Andy","family":"Cheadle","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pvt. Ltd, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Ferraris","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Joshi","sequence":"additional","affiliation":[{"name":"Novartis Healthcare Pvt. Ltd, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Thompson","sequence":"additional","affiliation":[{"name":"Cerner Enviza, Malvern, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshani","family":"Shah","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vo","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00404.x"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.09.005"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13301"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0907-6"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0592-1"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000323925.29520.e7"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12055"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419835465"},{"key":"e_1_3_5_10_1","first-page":"133","article-title":"Patient satisfaction with prophylactic migraine medications","volume":"57","author":"Clark M","year":"2017","unstructured":"Clark M, Schwedt T, Tepper S, et\u00a0al. Patient satisfaction with prophylactic migraine medications. Headache. 2017;57:133.","journal-title":"Headache"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.1.22"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102416678382"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414547138"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0946-z"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13157"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0964-5"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0974-3"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13599"},{"key":"e_1_3_5_19_1","unstructured":"Aimovig prescribing information. 2018 [cited 2020 Dec 10]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/761077s000lbl.pdf"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03839-x"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418759786"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01127-0"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01102-9"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00417"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32534-0"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01143-0"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01151-0"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30083-2"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01344-1"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13456"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2196\/13029"},{"key":"e_1_3_5_33_1","first-page":"103","article-title":"Real-world trends in characteristics of migraine patients newly initiated on erenumab in the United States","volume":"27","author":"Fang J","year":"2020","unstructured":"Fang J, Korrer S, Johnson J, et\u00a0al. Real-world trends in characteristics of migraine patients newly initiated on erenumab in the United States. Eur J Neurology. 2020;27:103\u2013522.","journal-title":"Eur J Neurology"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252808.97649.21"},{"key":"e_1_3_5_35_1","first-page":"293","article-title":"Treatment patterns, healthcare resource use, and outcomes of patients with chronic and episodic migraines treated with erenumab: a multicenter chart-review study","volume":"10","author":"Faust E","year":"2019","unstructured":"Faust E, Pivneva I, Betts K, et\u00a0al. Treatment patterns, healthcare resource use, and outcomes of patients with chronic and episodic migraines treated with erenumab: a multicenter chart-review study. Headache. 2019;10:293\u2013306.","journal-title":"Headache"},{"key":"e_1_3_5_36_1","first-page":"199","article-title":"Erenumab prescription early view: patient characteristics, treatment patterns and medication adherence in the United States","volume":"61","author":"Hines D","year":"2019","unstructured":"Hines D, Shah S, Multani J, et\u00a0al. Erenumab prescription early view: patient characteristics, treatment patterns and medication adherence in the United States. Headache. 2019;61:199\u2013200.","journal-title":"Headache"},{"key":"e_1_3_5_37_1","doi-asserted-by":"crossref","unstructured":"Bogdanov A Chia V Szekely C et\u00a0al. Early use of erenumab in US real world practice. Cephalalgia Rep. 2021;4(4):251581632110204.","DOI":"10.1177\/25158163211020419"},{"key":"e_1_3_5_38_1","first-page":"58","article-title":"CGRP monoclonal antibodies for chronic migraine: year 1 of clinical use","volume":"19","author":"Robbins L.","year":"2019","unstructured":"Robbins L. CGRP monoclonal antibodies for chronic migraine: year 1 of clinical use. Pract Pain Manage. 2019;19:58\u201362.","journal-title":"Pract Pain Manage"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2023.2191479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T13:43:49Z","timestamp":1702647829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2023.2191479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/03007995.2023.2191479"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2023.2191479","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}